Role of hypertension in the metabolic syndrome: Who is affected? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-11

AUTHORS

Gladys Velarde, Bradford C. Berk

ABSTRACT

Hypertension is one of the components of the metabolic syndrome. The “deadly quartet,” as this syndrome is often referred to, also includes atherogenic dyslipidemia; hyperglycemia and/or insulin resistance (IR); and abdominal obesity. More than 47 million people in the United States have the metabolic syndrome, with a higher prevalence in certain ethnic groups. This is expected to rise significantly in the future, in large part due to the obesity epidemic. The relative contribution of each of the constituents of this syndrome varies according to the population in which it occurs, but the significance of these variations is not known. In this article, we review the role of hypertension in the metabolic syndrome, its complex association with obesity and IR, and its disproportionate contribution to the syndrome in certain ethnic groups (specifically US blacks). More... »

PAGES

418-426

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11906-005-0036-x

DOI

http://dx.doi.org/10.1007/s11906-005-0036-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051822855

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16386197


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Incidence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metabolic Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.16416.34", 
          "name": [
            "Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Velarde", 
        "givenName": "Gladys", 
        "id": "sg:person.016455534201.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016455534201.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.16416.34", 
          "name": [
            "Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berk", 
        "givenName": "Bradford C.", 
        "id": "sg:person.012523312277.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012523312277.63"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00402173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052589861", 
          "https://doi.org/10.1007/bf00402173"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-11", 
    "datePublishedReg": "2005-11-01", 
    "description": "Hypertension is one of the components of the metabolic syndrome. The \u201cdeadly quartet,\u201d as this syndrome is often referred to, also includes atherogenic dyslipidemia; hyperglycemia and/or insulin resistance (IR); and abdominal obesity. More than 47 million people in the United States have the metabolic syndrome, with a higher prevalence in certain ethnic groups. This is expected to rise significantly in the future, in large part due to the obesity epidemic. The relative contribution of each of the constituents of this syndrome varies according to the population in which it occurs, but the significance of these variations is not known. In this article, we review the role of hypertension in the metabolic syndrome, its complex association with obesity and IR, and its disproportionate contribution to the syndrome in certain ethnic groups (specifically US blacks).", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11906-005-0036-x", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1021183", 
        "issn": [
          "1522-6417", 
          "1534-3111"
        ], 
        "name": "Current Hypertension Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "keywords": [
      "role of hypertension", 
      "metabolic syndrome", 
      "insulin resistance", 
      "certain ethnic groups", 
      "deadly quartet", 
      "atherogenic dyslipidemia", 
      "abdominal obesity", 
      "high prevalence", 
      "obesity epidemic", 
      "syndrome", 
      "ethnic groups", 
      "hypertension", 
      "obesity", 
      "dyslipidemia", 
      "complex association", 
      "hyperglycemia", 
      "group", 
      "prevalence", 
      "United States", 
      "epidemic", 
      "association", 
      "role", 
      "relative contribution", 
      "population", 
      "significance", 
      "resistance", 
      "disproportionate contribution", 
      "people", 
      "large part", 
      "constituents", 
      "part", 
      "components", 
      "future", 
      "contribution", 
      "article", 
      "variation", 
      "state", 
      "quartet"
    ], 
    "name": "Role of hypertension in the metabolic syndrome: Who is affected?", 
    "pagination": "418-426", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051822855"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11906-005-0036-x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16386197"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11906-005-0036-x", 
      "https://app.dimensions.ai/details/publication/pub.1051822855"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_409.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11906-005-0036-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11906-005-0036-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11906-005-0036-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11906-005-0036-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11906-005-0036-x'


 

This table displays all metadata directly associated to this object as RDF triples.

138 TRIPLES      21 PREDICATES      71 URIs      62 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11906-005-0036-x schema:about N20d630b5b5054221805de5cfaaaecb98
2 N271e7c3ac9f845a098bf8a464a73f5dc
3 N289c662593d8481ba5dba569ffea9a34
4 N58da4063650246bd830766b4ad2c5e04
5 Nedf3f755e69842a18a9c40fea1bda807
6 Nf0e5c284ce084631833116b31c82ee79
7 Nfc035fdce46340698d07015e5de293ec
8 anzsrc-for:11
9 anzsrc-for:1103
10 schema:author Nfcf6c22872b34ee186e89eddb7d23fbe
11 schema:citation sg:pub.10.1007/bf00402173
12 schema:datePublished 2005-11
13 schema:datePublishedReg 2005-11-01
14 schema:description Hypertension is one of the components of the metabolic syndrome. The “deadly quartet,” as this syndrome is often referred to, also includes atherogenic dyslipidemia; hyperglycemia and/or insulin resistance (IR); and abdominal obesity. More than 47 million people in the United States have the metabolic syndrome, with a higher prevalence in certain ethnic groups. This is expected to rise significantly in the future, in large part due to the obesity epidemic. The relative contribution of each of the constituents of this syndrome varies according to the population in which it occurs, but the significance of these variations is not known. In this article, we review the role of hypertension in the metabolic syndrome, its complex association with obesity and IR, and its disproportionate contribution to the syndrome in certain ethnic groups (specifically US blacks).
15 schema:genre article
16 schema:isAccessibleForFree false
17 schema:isPartOf Nef67e6a1980a43949b690f9bf3fbbb1b
18 Nf7fb3a562019420e96657efa5b09f502
19 sg:journal.1021183
20 schema:keywords United States
21 abdominal obesity
22 article
23 association
24 atherogenic dyslipidemia
25 certain ethnic groups
26 complex association
27 components
28 constituents
29 contribution
30 deadly quartet
31 disproportionate contribution
32 dyslipidemia
33 epidemic
34 ethnic groups
35 future
36 group
37 high prevalence
38 hyperglycemia
39 hypertension
40 insulin resistance
41 large part
42 metabolic syndrome
43 obesity
44 obesity epidemic
45 part
46 people
47 population
48 prevalence
49 quartet
50 relative contribution
51 resistance
52 role
53 role of hypertension
54 significance
55 state
56 syndrome
57 variation
58 schema:name Role of hypertension in the metabolic syndrome: Who is affected?
59 schema:pagination 418-426
60 schema:productId N246ed1f611d840119eedcf4e57a2242f
61 N9d9e4d8ac2d541f48a93957ee86016df
62 Ncb9fddb2680241d5a139eb063a2712b6
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051822855
64 https://doi.org/10.1007/s11906-005-0036-x
65 schema:sdDatePublished 2022-10-01T06:33
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher Ndd62f7f91a784caa9b1415dbbead0bbc
68 schema:url https://doi.org/10.1007/s11906-005-0036-x
69 sgo:license sg:explorer/license/
70 sgo:sdDataset articles
71 rdf:type schema:ScholarlyArticle
72 N20d630b5b5054221805de5cfaaaecb98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name United States
74 rdf:type schema:DefinedTerm
75 N246ed1f611d840119eedcf4e57a2242f schema:name doi
76 schema:value 10.1007/s11906-005-0036-x
77 rdf:type schema:PropertyValue
78 N271e7c3ac9f845a098bf8a464a73f5dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Metabolic Syndrome
80 rdf:type schema:DefinedTerm
81 N289c662593d8481ba5dba569ffea9a34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Risk Factors
83 rdf:type schema:DefinedTerm
84 N58da4063650246bd830766b4ad2c5e04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Lipids
86 rdf:type schema:DefinedTerm
87 N9d9e4d8ac2d541f48a93957ee86016df schema:name pubmed_id
88 schema:value 16386197
89 rdf:type schema:PropertyValue
90 Ncb9fddb2680241d5a139eb063a2712b6 schema:name dimensions_id
91 schema:value pub.1051822855
92 rdf:type schema:PropertyValue
93 Ndd62f7f91a784caa9b1415dbbead0bbc schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 Nedf3f755e69842a18a9c40fea1bda807 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Hypertension
97 rdf:type schema:DefinedTerm
98 Nef67e6a1980a43949b690f9bf3fbbb1b schema:volumeNumber 7
99 rdf:type schema:PublicationVolume
100 Nf0e5c284ce084631833116b31c82ee79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Humans
102 rdf:type schema:DefinedTerm
103 Nf7fb3a562019420e96657efa5b09f502 schema:issueNumber 6
104 rdf:type schema:PublicationIssue
105 Nfb5f016217df4d408cad61edb9d8563e rdf:first sg:person.012523312277.63
106 rdf:rest rdf:nil
107 Nfc035fdce46340698d07015e5de293ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Incidence
109 rdf:type schema:DefinedTerm
110 Nfcf6c22872b34ee186e89eddb7d23fbe rdf:first sg:person.016455534201.95
111 rdf:rest Nfb5f016217df4d408cad61edb9d8563e
112 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
113 schema:name Medical and Health Sciences
114 rdf:type schema:DefinedTerm
115 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
116 schema:name Clinical Sciences
117 rdf:type schema:DefinedTerm
118 sg:journal.1021183 schema:issn 1522-6417
119 1534-3111
120 schema:name Current Hypertension Reports
121 schema:publisher Springer Nature
122 rdf:type schema:Periodical
123 sg:person.012523312277.63 schema:affiliation grid-institutes:grid.16416.34
124 schema:familyName Berk
125 schema:givenName Bradford C.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012523312277.63
127 rdf:type schema:Person
128 sg:person.016455534201.95 schema:affiliation grid-institutes:grid.16416.34
129 schema:familyName Velarde
130 schema:givenName Gladys
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016455534201.95
132 rdf:type schema:Person
133 sg:pub.10.1007/bf00402173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052589861
134 https://doi.org/10.1007/bf00402173
135 rdf:type schema:CreativeWork
136 grid-institutes:grid.16416.34 schema:alternateName Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA
137 schema:name Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA
138 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...